Improving cancer stem cells killing in malignant melanoma
Br J Dermatol. 2024 Jan 29:ljae035. doi: 10.1093/bjd/ljae035. Online ahead of print.NO ABSTRACTPMID:38282338 | DOI:10.1093/bjd/ljae035 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 29, 2024 Category: Dermatology Authors: Daniele Bergamaschi Source Type: research

Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study
Br J Dermatol. 2024 Jan 29:ljae039. doi: 10.1093/bjd/ljae039. Online ahead of print.NO ABSTRACTPMID:38282350 | DOI:10.1093/bjd/ljae039 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 29, 2024 Category: Dermatology Authors: Nicholas A Trum Lu Chen Jasmine Zain Steven T Rosen Christiane Querfeld Source Type: research

Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab
Br J Dermatol. 2024 Jan 29:ljae036. doi: 10.1093/bjd/ljae036. Online ahead of print.NO ABSTRACTPMID:38282352 | DOI:10.1093/bjd/ljae036 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 29, 2024 Category: Dermatology Authors: Niamh Kearney Brian Kirby Source Type: research

Effectiveness and safety of major systemic treatments in classic and endemic Kaposi sarcoma: a multicenter retrospective study of 110 patients
Br J Dermatol. 2024 Jan 25:ljae032. doi: 10.1093/bjd/ljae032. Online ahead of print.NO ABSTRACTPMID:38270968 | DOI:10.1093/bjd/ljae032 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 25, 2024 Category: Dermatology Authors: Chlo é Grolleau Anouk Walter-Petrich Nicolas Dupin Johan Chanal Ouidad Zehou Claire Montlahuc Barouyr Baroudjian Laetitia Da Meda Matthieu Resche-Rigon Laurence Le Cleach C éleste Lebbé Source Type: research

Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort
Br J Dermatol. 2024 Jan 23:ljad500. doi: 10.1093/bjd/ljad500. Online ahead of print.NO ABSTRACTPMID:38263520 | DOI:10.1093/bjd/ljad500 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 24, 2024 Category: Dermatology Authors: Hannah L Cornman Katherine A Whang Emily Ma Prachi Aggarwal Anusha Kambala Sriya V Reddy Sylvie Gabriel Shawn G Kwatra Source Type: research

Mycophenolate mofetil inhibits Merkel cell carcinoma growth
Br J Dermatol. 2024 Jan 24:ljae018. doi: 10.1093/bjd/ljae018. Online ahead of print.NO ABSTRACTPMID:38266271 | DOI:10.1093/bjd/ljae018 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 24, 2024 Category: Dermatology Authors: Khalid A Garman Nicholas Thoreson Jennifer Strong Patrick Hallaert Tara Gelb Min Shen Matthew D Hall Isaac Brownell Source Type: research

LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus-positive and -negative Merkel cell carcinoma
CONCLUSIONS: Tumours with weak expression of LT tend to co-express genes related to squamous differentiation and cell cycle, and to have a higher mutational burden. These findings are congruent with those of earlier studies.PMID:38261397 | DOI:10.1093/bjd/ljae033 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Authors: Juan Torre-Castro Marta Rodr íguez Ruth Alonso-Alonso Mar ía Dolores Mendoza Cembranos Jes ús Frutos Díaz-Alejo Marcos Rebollo-Gonz ález Jennifer Borreg ón Laura N ájera Botello Ignacio Mahillo-Fern ández Mathab Samimi Thibault Kervarrec Luis Requ Source Type: research

iscorEB-p: A patient-reported outcome measure for Epidermolysis bullosa. Psychometric properties of the Patient Score from the Instrument for Scoring Clinical Outcome of Research for EB
CONCLUSIONS: In conclusion, the iscorEB-p is a reliable and valid instrument to assess the patient-reported view on the health status of EB patients.PMID:38261404 | DOI:10.1093/bjd/ljae019 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Authors: Gudrun Salamon Sophie Strobl Ursula Field-Werners Anja Diem Agnes Schwieger-Briel Elena Pope Source Type: research

The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children
CONCLUSIONS: The proxy version of RECAP is a valid, reliable and responsive measurement instrument for measuring eczema control in children with AD. An improvement of ≥6 points can be regarded as real and important change in children with AD.PMID:38262143 | DOI:10.1093/bjd/ljae017 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Authors: Avi ël Ragamin Junfen Zhang Suzanne G M A Pasmans Renske Schappin Geertruida L E Romeijn Maroos A van Reusel Jart A F Oosterhaven Marie L A Schuttelaar Source Type: research

Editor's Choice - John Ingram - February  2024
Br J Dermatol. 2024 Jan 23;190(2):i-ii. doi: 10.1093/bjd/ljad496.NO ABSTRACTPMID:38262592 | DOI:10.1093/bjd/ljad496 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Source Type: research

Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1
Br J Dermatol. 2024 Jan 23;190(2):e20. doi: 10.1093/bjd/ljad515.NO ABSTRACTPMID:38262593 | DOI:10.1093/bjd/ljad515 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Source Type: research

A decreasing trend of atopic dermatitis among children in Sweden
Br J Dermatol. 2024 Jan 23;190(2):e17. doi: 10.1093/bjd/ljad514.NO ABSTRACTPMID:38262594 | DOI:10.1093/bjd/ljad514 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Source Type: research

Genes associated with nodular melanoma
Br J Dermatol. 2024 Jan 23;190(2):e18. doi: 10.1093/bjd/ljad511.NO ABSTRACTPMID:38262595 | DOI:10.1093/bjd/ljad511 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Source Type: research

Omalizumab used to treat bullous pemphigoid resistant to other treatments
Br J Dermatol. 2024 Jan 23;190(2):e23. doi: 10.1093/bjd/ljad510.NO ABSTRACTPMID:38262596 | DOI:10.1093/bjd/ljad510 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Source Type: research

A study using machine learning to help identify subgroups of adults with atopic dermatitis
Br J Dermatol. 2024 Jan 23;190(2):e19. doi: 10.1093/bjd/ljad509.NO ABSTRACTPMID:38262597 | DOI:10.1093/bjd/ljad509 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - January 23, 2024 Category: Dermatology Source Type: research